Vocimagene amiretrorepvec Uses, Dosage, Side Effects and more

Vocimagene amiretrorepvec is under investigation in clinical trial NCT02576665 (A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)).

Attribute	Details
Trade Name	Vocimagene amiretrorepvec
Generic	Vocimagene amiretrorepvec
Vocimagene amiretrorepvec Other Names	Vocimagene amiretrorepvec
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph